It can be read here
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Thursday, August 1, 2013
Compounding Legislation’s Rationale Gets Boost From GAO – But Its Details Don’t
By Cathy Dombrowski / Email the Author / Jul. 31, 2013
Word Count: 903 / Article # 14130731005 / Posted: July 31 2013 8:00 PM
Executive Summary
A report from the federal watchdog agency backs up FDA’s quest for legislative action, but makes no specific recommendations on how to improve the agency’s capabilities to regulate compounding pharmacies.
Study: Compounding pharmacy oversight inconsistent
BOSTON (AP) — A new federal report has concluded that the authority to regulate pharmacies engaged in drug compounding is ‘‘unclear’’ and ‘‘inconsistent’’ at the state and federal levels.
The Government Accountability Office also found that federal circuit court decisions have given the Food and Drug Administration different oversight authority in different parts of the country.
continue to read here
Subscribe to:
Posts (Atom)